Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

The success of allogeneic hematopoietic cell transplantation (HCT) is typically assessed as individual complications, including graft-versus-host disease (GVHD), relapse, or death, yet no one factor can completely characterize cure without ongoing morbidity. We examined a novel composite end point o...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood
Главные авторы: Holtan, Shernan G., DeFor, Todd E., Lazaryan, Aleksandr, Bejanyan, Nelli, Arora, Mukta, Brunstein, Claudio G., Blazar, Bruce R., MacMillan, Margaret L., Weisdorf, Daniel J.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2015
Предметы:
Transplantation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4335084/
https://ncbi.nlm.nih.gov/pubmed/25593335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-10-609032
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы